CD6 as a potential target for treating multiple sclerosis.

Proc. Natl. Acad. Sci. U.S.A.2017 Mar 07;114(10):2687-2692. Epub 2017 Feb 16

{{ author.authorName }}^{{{getOrganisationIndexOf(author)}}} {{ author.authorName }}^{{{getOrganisationIndexOf(author)}}}

+ et al

[No authors listed]

Author information

) CD6 is a potential new target for treating MS and potentially other T-cell-driven autoimmune conditions.

KEYWORDS: {{ getKeywords(articleDetailText.words) }}

‹ › ×

Sample name	Organism	Experiment title	Sample type	Library instrument	Attributes
Sample name	Organism	Experiment title	Sample type	Library instrument	{{attr}}
{{ dataList.sampleTitle }}	{{ dataList.organism }}	{{ dataList.expermentTitle }}	{{ dataList.sampleType }}	{{ dataList.libraryInstrument }}	{{ showAttributeName(index,attr,dataList.attributes) }}